- Home
- LIDR vs SILO Comparison
LIDR vs SILO Comparison
Compare LIDR & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- SILO
- Stock Information
- Founded
- LIDR 2013
- SILO 2010
- Country
- LIDR United States
- SILO United States
- Employees
- LIDR N/A
- SILO N/A
- Industry
- LIDR Auto Parts:O.E.M.
- SILO Apparel
- Sector
- LIDR Consumer Discretionary
- SILO Consumer Discretionary
- Exchange
- LIDR Nasdaq
- SILO Nasdaq
- Market Cap
- LIDR 9.8M
- SILO 3.1M
- IPO Year
- LIDR N/A
- SILO N/A
- Fundamental
- Price
- LIDR $0.71
- SILO $0.44
- Analyst Decision
- LIDR Hold
- SILO
- Analyst Count
- LIDR 1
- SILO 0
- Target Price
- LIDR N/A
- SILO N/A
- AVG Volume (30 Days)
- LIDR 1.2M
- SILO 639.0K
- Earning Date
- LIDR 05-08-2025
- SILO 05-09-2025
- Dividend Yield
- LIDR N/A
- SILO N/A
- EPS Growth
- LIDR N/A
- SILO N/A
- EPS
- LIDR N/A
- SILO N/A
- Revenue
- LIDR $246,000.00
- SILO $72,102.00
- Revenue This Year
- LIDR $2,677.23
- SILO $1.86
- Revenue Next Year
- LIDR $409.09
- SILO N/A
- P/E Ratio
- LIDR N/A
- SILO N/A
- Revenue Growth
- LIDR N/A
- SILO N/A
- 52 Week Low
- LIDR $0.49
- SILO $0.41
- 52 Week High
- LIDR $4.30
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- LIDR 50.26
- SILO 31.78
- Support Level
- LIDR $0.71
- SILO $0.41
- Resistance Level
- LIDR $0.84
- SILO $0.49
- Average True Range (ATR)
- LIDR 0.06
- SILO 0.08
- MACD
- LIDR 0.00
- SILO -0.01
- Stochastic Oscillator
- LIDR 49.61
- SILO 4.78
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.